Grants paid by Spinal Muscular Atrophy Foundation
EIN 01-0759380 · New York, WY · Form 990-PF, Part XV · NTEE B99
Spinal Muscular Atrophy Foundation of New York, WY (EIN 01-0759380) reported 25 grants paid totaling $3,627,462 to 10 recipients in tax years 2020–2024, on Form 990-PF, Part XV. It also reported $8,514,330 approved for future payment, which is listed separately and not included in the total. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$3,627,462
25 grants
Recipients
10
distinct organizations
Tax years
2020–2024
4 filings in the corpus
Approved for future payment
$8,514,330
19 commitments · not included in grants paid
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2020 | 4 | $326,352 | $1,100,000 |
| 2022 | 1 | $653,689 | $1,423,413 |
| 2023 | 9 | $1,155,632 | $2,179,287 |
| 2024 | 11 | $1,491,789 | $3,811,630 |
Top recipients
The 10 recipients receiving the most from Spinal Muscular Atrophy Foundation, by grants paid, out of 10 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Stanford University 26-4580872 | C | Palo Alto, CA | 15 | $2,380,147 | 2024 |
| University of Florida | U | Gainesville, FL | 2 | $296,860 | 2024 |
| John Hopkins University | U | Baltimore, MD | 1 | $238,814 | 2024 |
| Swiss Federal Technology Institute of Lausanne | U | LAUSANNE | 1 | $218,006 | 2024 |
| Columbia University 82-2244803 | B | New York, NY | 1 | $150,000 | 2020 |
| University of Edinburgh | U | EDINBURGH | 1 | $141,212 | 2024 |
| Boston Children's Hospital | U | Boston, MA | 1 | $98,571 | 2024 |
| Children's Hospital of Boston | U | Boston, MA | 1 | $88,626 | 2020 |
| Children's Hospital of Philadelphia 23-1352166 | B | Philadelphia, PA | 1 | $12,726 | 2020 |
| Muscular Distrophy Association 13-1665552 | D | Chicago, IL | 1 | $2,500 | 2024 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 44 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Harvard University Cambridge, MA | C | $690,000 | approved, future | TESTING SATELLITE CELL REPLACEMENT IN SMA MODELS | 202543219349104244 |
| 2024 | Harvard University Cambridge, MA | C | $690,000 | approved, future | DEVELOPMENT OF BIOMATERIALS TO REGENERATE MUSCLE AND MOTOR NEURONS | 202543219349104244 |
| 2024 | Stanford University Palo Alto, CA | C | $653,281 | approved, future | CHARACTERIZATION OF NEURON-GLIAL-IMMUNE CELL INTERACTIONS IN SMA | 202543219349104244 |
| 2024 | Boston Children's Hospital Boston, MA | U | $591,429 | approved, future | TESTING THERAPEUTICS THAT PROMOTE NEURON GROWTH IN SMA MODELS | 202543219349104244 |
| 2024 | Stanford University Palo Alto, CA | C | $350,903 | approved, future | OVERSIGHT ON THE STANFORD-SMA FOUNDATION REGENERATIVE MEDICINE PROGRAM PROJECTS | 202543219349104244 |
| 2024 | University of Edinburgh EDINBURGH | U | $333,776 | approved, future | CHARACTERIZATION OF NEUROMUSCULAR JUNCTIONS IN SMA | 202543219349104244 |
| 2024 | John Hopkins University Baltimore, MD | U | $238,814 | approved, future | CHARACTERIZATION OF GENE EXPRESSION IN MOTOR NEURONS IN SMA | 202543219349104244 |
| 2024 | John Hopkins University Baltimore, MD | U | $238,814 | paid | CHARACTERIZATION OF GENE EXPRESSION IN MOTOR NEURONS IN SMA | 202543219349104244 |
| 2024 | Swiss Federal Technology Institute of Lausanne LAUSANNE | U | $218,006 | paid | TESTING OF MITOCHONDRIAL MODULATORS IN SMA MODELS | 202543219349104244 |
| 2024 | Stanford University Palo Alto, CA | C | $207,000 | paid | GENERATION OF SPINAL CORD MOTOR NEURONS FROM PLURIPOTENT CELLS | 202543219349104244 |
| 2024 | University of Florida Gainesville, FL | U | $197,907 | paid | CHARACTERIZATION OF MUSCLE ENVIRONMENT IN SMA | 202543219349104244 |
| 2024 | Stanford University Palo Alto, CA | C | $167,825 | paid | OVERSIGHT ON THE STANFORD-SMA FOUNDATION REGENERATIVE MEDICINE PROGRAM PROJECTS | 202543219349104244 |
| 2024 | University of Edinburgh EDINBURGH | U | $141,212 | paid | CHARACTERIZATION OF NEUROMUSCULAR JUNCTIONS IN SMA | 202543219349104244 |
| 2024 | Stanford University Palo Alto, CA | C | $117,494 | paid | CHARACTERIZATION OF NEURON-GLIAL-IMMUNE CELL INTERACTIONS IN SMA | 202543219349104244 |
| 2024 | Swiss Federal Technology Institute of Lausanne LAUSANNE | U | $106,002 | approved, future | TESTING OF MITOCHONDRIAL MODULATORS IN SMA MODELS | 202543219349104244 |
| 2024 | University of Florida Gainesville, FL | U | $98,953 | approved, future | CHARACTERIZATION OF MUSCLE ENVIRONMENT IN SMA | 202543219349104244 |
| 2024 | Boston Children's Hospital Boston, MA | U | $98,571 | paid | TESTING THERAPEUTICS THAT PROMOTE NEURON GROWTH IN SMA MODELS | 202543219349104244 |
| 2024 | Stanford University Palo Alto, CA | C | $69,000 | paid | CHARACTERIZATION OF MUSCLE IN SMA PATIENTS | 202543219349104244 |
| 2024 | University of Pittsburgh Pittsburgh, PA | B | $58,472 | approved, future | TESTING EFFECTS OF SPINAL CORD STIMULATION IN SMA PATIENTS | 202543219349104244 |
| 2024 | Stanford University Palo Alto, CA | C | $33,460 | paid | DEVELOPMENT OF NONINVASIVE GENE EDITING METHODS | 202543219349104244 |
| 2024 | Muscular Distrophy Association Chicago, IL | D | $2,500 | paid | SUPPORT OF MUSCLE REGENERATION SUMMIT WITH KEY MUSCLE EXPERTS | 202543219349104244 |
| 2023 | Stanford University Palo Alto, CA | C | $770,775 | approved, future | CHARACTERIZATION OF NEURON-GLIAL-IMMUNE CELL INTERACTIONS IN SMA | 202443209349108194 |
| 2023 | Stanford University Palo Alto, CA | C | $518,728 | approved, future | OVERSIGHT ON THE STANFORD-SMA FOUNDATION REGENERATIVE MEDICINE PROGRAM PROJECTS | 202443209349108194 |
| 2023 | University of Florida Gainesville, FL | U | $296,860 | approved, future | CHARACTERIZATION OF MUSCLE ENVIRONMENT IN SMA | 202443209349108194 |
| 2023 | University of Edinburgh EDINBURGH | U | $282,424 | approved, future | CHARACTERIZATION OF NEUROMUSCULAR JUNCTIONS IN SMA | 202443209349108194 |
| 2023 | Stanford University Palo Alto, CA | C | $207,000 | paid | ANALYSIS OF GENE EXPRESSION AND SPLICING IN SMA PATIENT CELLS | 202443209349108194 |
| 2023 | Stanford University Palo Alto, CA | C | $207,000 | approved, future | GENERATION OF SPINAL CORD MOTOR NEURONS FROM PLURIPOTENT CELLS | 202443209349108194 |
| 2023 | Stanford University Palo Alto, CA | C | $162,935 | paid | OVERSIGHT ON THE STANFORD-SMA FOUNDATION REGENERATIVE MEDICINE PROGRAM PROJECTS | 202443209349108194 |
| 2023 | Stanford University Palo Alto, CA | C | $138,000 | paid | CHARACTERIZATION OF MUSCLE IN SMA PATIENTS | 202443209349108194 |
| 2023 | Stanford University Palo Alto, CA | C | $138,000 | paid | GENERATION OF SPINAL CORD MOTOR NEURONS FROM PLURIPOTENT CELLS | 202443209349108194 |
| 2023 | Stanford University Palo Alto, CA | C | $138,000 | paid | GENERATION OF HINDBRAIN MOTOR NEURONS FROM PLURIPOTENT CELLS | 202443209349108194 |
| 2023 | Stanford University Palo Alto, CA | C | $117,494 | paid | CHARACTERIZATION OF NEURON-GLIAL-IMMUNE CELL INTERACTIONS IN SMA | 202443209349108194 |
| 2023 | University of Florida Gainesville, FL | U | $98,953 | paid | CHARACTERIZATION OF MUSCLE ENVIRONMENT IN SMA | 202443209349108194 |
| 2023 | Stanford University Palo Alto, CA | C | $86,250 | paid | GENERATION AND CHARACTERIZATION OF SKELETAL MUSCLE FROM INDUCED PLURIPOTENT STEM CELLS FROM SMA PATIENTS | 202443209349108194 |
| 2023 | Stanford University Palo Alto, CA | C | $69,000 | paid | DEVELOPMENT OF NONINVASIVE GENE EDITING METHODS | 202443209349108194 |
| 2023 | Stanford University Palo Alto, CA | C | $69,000 | approved, future | CHARACTERIZATION OF MUSCLE IN SMA PATIENTS | 202443209349108194 |
| 2023 | Stanford University Palo Alto, CA | C | $34,500 | approved, future | DEVELOPMENT OF NONINVASIVE GENE EDITING METHODS | 202443209349108194 |
| 2022 | Stanford University Palo Alto, CA | C | $1,423,413 | approved, future | MODAILTY-AGNOSTIC DRUG PROTOTYPING RESEARCH PROJECTS | 202343199349107749 |
| 2022 | Stanford University Palo Alto, CA | C | $653,689 | paid | MODAILTY-AGNOSTIC DRUG PROTOTYPING RESEARCH PROJECTS | 202343199349107749 |
| 2020 | Stanford University Palo Alto, CA | C | $1,100,000 | approved, future | MODAILTY-AGNOSTIC DRUG PROTOTYPING RESEARCH PROJECTS | 202133199349102653 |
| 2020 | Columbia University New York, NY | B | $150,000 | paid | TO SUPPORT PNCR RESEARCH | 202133199349102653 |
| 2020 | Children's Hospital of Boston Boston, MA | U | $88,626 | paid | TO SUPPORT PNCR RESEARCH | 202133199349102653 |
| 2020 | Stanford University Palo Alto, CA | C | $75,000 | paid | TO SUPPORT PNCR RESEARCH | 202133199349102653 |
| 2020 | Children's Hospital of Philadelphia Philadelphia, PA | B | $12,726 | paid | TO SUPPORT PNCR RESEARCH | 202133199349102653 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990PF | 2024 | 2024-12-31 | not stated | 2024v5.2 | 202543219349104244 |
| 990PF | 2023 | 2023-12-31 | not stated | 2023v5.1 | 202443209349108194 |
| 990PF | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202343199349107749 |
| 990PF | 2020 | 2020-12-31 | not stated | 2020v4.1 | 202133199349102653 |
Derived from IRS Form 990-PF e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/010759380.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.